Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients-Reference-Cited by-同舟云学术

Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients

Published:2018-05-22 Issue:6 Volume:5 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Talbot H Keipp¹,Dunning Andrew J²^ORCID,Robertson Corwin A²,Landolfi Victoria A²,Greenberg David P²³,DiazGranados Carlos A²

Affiliation:

1. Vanderbilt University Medical Center, Nashville, Tennessee

2. Sanofi Pasteur, Swiftwater, Pennsylvania

3. Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Abstract

Abstract Passive surveillance data had signaled the possibility of gastrointestinal adverse events occurring after the administration of high-dose inactivated influenza vaccine (IIV-HD). However, in a large, prospective randomized clinical trial, rates of serious gastrointestinal events were no greater among IIV-HD recipients than among those who received a standard-dose influenza vaccine.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/5/6/ofy115/33577340/ofy115.pdf

Reference9 articles.

1. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010;Moro;Clin Infect Dis,2012

2. Efficacy of high-dose versus standard-dose influenza vaccine in older adults;DiazGranados;N Engl J Med,2014

3. Guideline for clinical safety data management: definitions and standards for expedited reporting (E2A);Harmonisation ICo;Fed Regist,1995

4. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine;Talbot;Vaccine,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age;Reviews in Medical Virology;2022-02-04